China Health Group Limited has announced the successful completion of a new share subscription under a specific mandate, alongside a rights issue. The rights issue was conducted on the basis of three rights shares for every ten shares held on the record date, at an issue price of HK$0.10 per rights share. Following these transactions, the company's total issued share capital increased to 1,339,138,191 shares. Key shareholders, including Mr. Zhang and Mr. Ying, increased their stakes through direct and indirect holdings. The company stated that the Board is confident in the accuracy of the information provided and has undertaken thorough due diligence regarding this capital raising initiative.